Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap W Groothoff

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Orphanet Journal of Rare Diseases|December 24, 2024
Application of four pricing models for orphan medicines: a case study for lumasiranNoa Rosenberg, Evert Manders, Sibren van den Berg, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapyJérôme Harambat, Karlijn J van Stralen, Laura Espinosa, et al.
Kidney International|October 20, 2023
Corrigendum to "Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy." Kidney International, 2023;104:203-204Elisabeth L Metry, Lisa J Deesker, Sander F Garrelfs, et al.
Kidney International|June 22, 2023
Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapyElisabeth L Metry, Lisa J Deesker, Sander F Garrelfs, et al.
Pediatric Nephrology (Berlin, Germany)|October 21, 2016
Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA RegistryTuula Hölttä, Marjolein Bonthuis, Karlijn J Van Stralen, et al.
Pediatric Nephrology (Berlin, Germany)|April 8, 2021
Transplantation outcomes in patients with primary hyperoxaluria: a systematic reviewElisabeth L Metry, Liza M M van Dijk, Hessel Peters-Sengers, et al.
Journal of Clinical Research in Pediatric Endocrinology|July 20, 2017
Is There an Association Between Cortisol and Hypertension in Overweight or Obese Children?Aleid Jg Wirix, Martijn Jj Finken, Ines A von Rosenstiel-Jadoul, et al.
Kidney International|March 5, 2023
Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1Sander F Garrelfs, Elisabeth L Metry, Dewi van Harskamp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 4, 2017
Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society for Paediatric Nephrology/European Renal Association - European Dialysis and Transplant Association RegistryLidwien A Tjaden, Kitty J Jager, Marjolein Bonthuis, et al.
Pediatric Nephrology (Berlin, Germany)|November 2, 2022
Risk factors for neurocognitive impairment and the relation with structural brain abnormality in children and young adults with severe chronic kidney diseaseSophie Lijdsman, Kim J Oostrom, Marit S van Sandwijk, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Orphanet Journal of Rare Diseases|December 24, 2024
Application of four pricing models for orphan medicines: a case study for lumasiranNoa Rosenberg, Evert Manders, Sibren van den Berg, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 7, 2012
Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapyJérôme Harambat, Karlijn J van Stralen, Laura Espinosa, et al.
Kidney International|October 20, 2023
Corrigendum to "Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy." Kidney International, 2023;104:203-204Elisabeth L Metry, Lisa J Deesker, Sander F Garrelfs, et al.
Kidney International|June 22, 2023
Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapyElisabeth L Metry, Lisa J Deesker, Sander F Garrelfs, et al.
Pediatric Nephrology (Berlin, Germany)|October 21, 2016
Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA RegistryTuula Hölttä, Marjolein Bonthuis, Karlijn J Van Stralen, et al.
Pediatric Nephrology (Berlin, Germany)|April 8, 2021
Transplantation outcomes in patients with primary hyperoxaluria: a systematic reviewElisabeth L Metry, Liza M M van Dijk, Hessel Peters-Sengers, et al.
Journal of Clinical Research in Pediatric Endocrinology|July 20, 2017
Is There an Association Between Cortisol and Hypertension in Overweight or Obese Children?Aleid Jg Wirix, Martijn Jj Finken, Ines A von Rosenstiel-Jadoul, et al.
Kidney International|March 5, 2023
Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1Sander F Garrelfs, Elisabeth L Metry, Dewi van Harskamp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 4, 2017
Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society for Paediatric Nephrology/European Renal Association - European Dialysis and Transplant Association RegistryLidwien A Tjaden, Kitty J Jager, Marjolein Bonthuis, et al.
Pediatric Nephrology (Berlin, Germany)|November 2, 2022
Risk factors for neurocognitive impairment and the relation with structural brain abnormality in children and young adults with severe chronic kidney diseaseSophie Lijdsman, Kim J Oostrom, Marit S van Sandwijk, et al.
Pageof 15